Glioblastoma Clinical Trials
Understanding Glioblastoma: What You Need to Know
Receiving a diagnosis of glioblastoma (GB) can feel overwhelming. As one of the most aggressive and malignant types of brain cancer, glioblastoma often presents unique challenges for patients and their loved ones. It’s the most common primary brain tumor, and while it is associated with a poor prognosis, advancements in research are offering hope for the future.
Current Treatment Options
Treatment for glioblastoma typically involves a combination of surgery, radiation therapy, and chemotherapy. These approaches aim to remove or reduce the tumor and slow its growth. However, even with aggressive treatment, the survival rate remains low, with most patients living 12–15 months after diagnosis.
At the Gillies McIndoe Research Institute, we understand how difficult this prognosis can be to hear. That’s why our scientists are working tirelessly to better understand this devastating disease and develop new therapies that could improve outcomes for patients like you or your loved one.
Ongoing Clinical Trials: Hope for the Future
We are currently recruiting patients for a Phase II clinical trial to investigate the effectiveness of a combination of repurposed drugs for glioblastoma. This trial builds on the success of our Phase I study, which demonstrated the safety of this approach. The goal is now to evaluate how well these drugs work in improving treatment outcomes, prolonging survival, and enhancing quality of life.
Clinical trials like these offer hope—not just for advancing science but for giving patients access to innovative treatments that may improve outcomes.
Interested in Participating?
If you or your loved one has been diagnosed with glioblastoma, you may be eligible to participate in our ongoing clinical trial. To learn more about the study, eligibility requirements, and how to get involved, contact our Clinical Study Coordinator, Ana, phone: 027 270 9919 or email: info@gmri.org.nz
Your participation could make a difference—not just for you, but for future patients facing the same diagnosis.
You can also watch the video to learn more about the clinical trial by the Gillies McIndoe Research Institute in collaboration with Te Whatu Ora - Health New Zealand.
Support
Gillies McIndoe Research Institute is a Registered Charity (CC43660) relying mainly on private philanthropy, including donations, bequests, corporate champions, grants and scholarships. You can donate now or contact us to learn how you can support us and enable our research to continue.